Liquid biopsy to detect minimal residual disease: methodology and impact

N Honoré, R Galot, C van Marcke, N Limaye… - Cancers, 2021 - mdpi.com
Simple Summary The field of liquid biopsy is rapidly evolving. Techniques that improve
accuracy are constantly being developed, and clinicians increasingly use liquid biopsy as a …

Exosomics in oral cancer diagnosis, prognosis, and therapeutics–An emergent and imperative non-invasive natural nanoparticle-based approach

A Bano, R Vats, P Yadav, R Bhardwaj - Critical Reviews in Oncology …, 2022 - Elsevier
Exosomes-the natural nanoparticles belonging to heterogeneous vesicles are released via
nearly all sorts of cells, including tumour cells, to oprate intercellular communication …

Emerging role of lncRNAs in drug resistance mechanisms in head and neck squamous cell carcinoma

JA Peña-Flores, M Bermúdez, R Ramos-Payán… - Frontiers in …, 2022 - frontiersin.org
Head and neck squamous cell carcinoma (HNSCC) originates in the squamous cell lining
the mucosal surfaces of the head and neck region, including the oral cavity, nasopharynx …

Dysregulation of non-coding RNAs mediates cisplatin resistance in hepatocellular carcinoma and therapeutic strategies

X Xu, X Yang, Y Song, B Chen, X Yu, T Xu… - Pharmacological …, 2022 - Elsevier
Hepatocellular carcinoma (HCC) is the fourth major contributor to cancer-related deaths
worldwide, and patients mostly have poor prognosis. Although several drugs have been …

Functional relevance of Extracellular vesicle-derived long non-coding and circular RNAs in Cancer Angiogenesis

JA Peña-Flores, D Muela-Campos… - Non-coding RNA, 2024 - mdpi.com
Extracellular vesicles (EVs) are defined as subcellular structures limited by a bilayer lipid
membrane that function as important intercellular communication by transporting active …

[HTML][HTML] m6A-related lncRNA signature for predicting prognosis and immune response in head and neck squamous cell carcinoma

J Yin, X He, F Qin, S Zheng, Y Huang, L Hu… - American Journal of …, 2022 - ncbi.nlm.nih.gov
Objectives: N6-methyladenosine (m 6 A) and long non-coding RNAs (lncRNAs) significantly
impact the prognosis and the response to immunotherapy in head and neck squamous cell …

Optimization of CRISPR–Cas system for clinical cancer therapy

X Meng, T Wu, Q Lou, K Niu, L Jiang… - Bioengineering & …, 2023 - Wiley Online Library
Cancer is a genetic disease caused by alterations in genome and epigenome and is one of
the leading causes for death worldwide. The exploration of disease development and …

Circulating long non-coding RNAs could be the potential prognostic biomarker for liquid biopsy for the clinical management of oral squamous cell carcinoma

R Dey Ghosh, S Guha Majumder - Cancers, 2022 - mdpi.com
Simple Summary Oral squamous cell carcinoma (OSCC) ranks as one of the deadliest
cancers in India. Only early detection of the disease with specific prognostic subtype, is the …

[HTML][HTML] Circulating long non-coding RNAs could be the potential prognostic biomarker for liquid biopsy for the clinical management of oral squamous cell carcinoma

RD Ghosh, SG Majumder - Cancers, 2022 - ncbi.nlm.nih.gov
Long non-coding RNA (lncRNA) have little or no coding potential. These transcripts are
longer than 200 nucleotides. Since lncRNAs are master regulators of almost all biological …

Prognostic prediction of head and neck squamous cell carcinoma: Construction of cuproptosis‐related long non‐coding RNA signature

Q Huang, Q You, N Zhu, Z Wu, Z Xiang… - Journal of Clinical …, 2022 - Wiley Online Library
Background Recently, a new type of programmed cell death, cuproptosis, has been
identified to play important role in the progression of tumors. We constructed a cuproptosis …